1: Drugs and Lactation Database (LactMed®) [Internet]. Bethesda (MD): National Institute of Child Health and Human Development; 2006–. Brivaracetam. 2021 Jun 21. PMID: 29999938.
2: Brivaracetam. Aust Prescr. 2017 Jun;40(3):112-113. doi: 10.18773/austprescr.2017.038. Epub 2017 May 10. PMID: 28798518; PMCID: PMC5478403.
3: LiverTox: Clinical and Research Information on Drug-Induced Liver Injury [Internet]. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases; 2012–. Brivaracetam. 2017 Oct 2. PMID: 31643850.
4: Bresnahan R, Panebianco M, Marson AG. Brivaracetam add-on therapy for drug- resistant epilepsy. Cochrane Database Syst Rev. 2022 Mar 14;3(3):CD011501. doi: 10.1002/14651858.CD011501.pub3. PMID: 35285519; PMCID: PMC8919456.
5: Steinhoff BJ, Klein P, Klitgaard H, Laloyaux C, Moseley BD, Ricchetti- Masterson K, Rosenow F, Sirven JI, Smith B, Stern JM, Toledo M, Zipfel PA, Villanueva V. Behavioral adverse events with brivaracetam, levetiracetam, perampanel, and topiramate: A systematic review. Epilepsy Behav. 2021 May;118:107939. doi: 10.1016/j.yebeh.2021.107939. Epub 2021 Apr 8. PMID: 33839453.
6: Dean L. Brivaracetam Therapy and CYP2C19 Genotype. 2018 May 15. In: Pratt VM, Scott SA, Pirmohamed M, Esquivel B, Kattman BL, Malheiro AJ, editors. Medical Genetics Summaries [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2012–. PMID: 29763212.
7: Khilari M, Nair PP, Jha BK. Brivaracetam: How Well Does It Fare as an Anti- Epileptic? A Review. Neurol India. 2021 Mar-Apr;69(2):284-293. doi: 10.4103/0028-3886.314584. PMID: 33904436.
8: Kappes JA, Hayes WJ, Strain JD, Farver DK. Brivaracetam: An Adjunctive Treatment for Partial-Onset Seizures. J Clin Pharmacol. 2017 Jul;57(7):811-817. doi: 10.1002/jcph.900. Epub 2017 Apr 10. PMID: 28394442.
9: Klein P, Tyrlikova I, Brazdil M, Rektor I. Brivaracetam for the treatment of epilepsy. Expert Opin Pharmacother. 2016;17(2):283-95. doi: 10.1517/14656566.2016.1135129. Epub 2016 Jan 13. PMID: 26760311.
10: Brivaracetam (Brivlera) [Internet]. Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2017 Feb. PMID: 28846216.
11: Makke Y, Abou-Khalil B. Brivaracetam efficacy and safety in focal epilepsy. Expert Rev Neurother. 2019 Oct;19(10):955-964. doi: 10.1080/14737175.2019.1631160. Epub 2019 Jun 24. PMID: 31195850.
12: von Rosenstiel P. Brivaracetam (UCB 34714). Neurotherapeutics. 2007 Jan;4(1):84-7. doi: 10.1016/j.nurt.2006.11.004. PMID: 17199019; PMCID: PMC7479692.
13: Karlov VA, Vlasov PN, Zhidkova IA, Kissin MY, Lebedeva AV, Lipatova LV, Mkrtchyan VR, Mukhin KY, Rudakova IG. Brivaratsetam v lechenii bol'nykh épilepsieĭ [Brivaracetam in the treatment of patients with epilepsy]. Zh Nevrol Psikhiatr Im S S Korsakova. 2017;117(9. Vyp. 2):55-62. Russian. doi: 10.17116/jnevro20171179255-62. PMID: 29213040.
14: Markham A. Brivaracetam: First Global Approval. Drugs. 2016 Mar;76(4):517-22. doi: 10.1007/s40265-016-0555-6. PMID: 26899665.
15: Lince-Rivera I, Córdoba NM, la Rosa JSO. Narrative review of brivaracetam for genetic generalized epilepsies. Seizure. 2022 Dec;103:72-81. doi: 10.1016/j.seizure.2022.10.009. Epub 2022 Oct 21. PMID: 36332461.
16: Hellerslia V, Asistido JM, Iyamu A. Brivaracetam for epilepsy. JAAPA. 2019 May;32(5):21-22. doi: 10.1097/01.JAA.0000554748.77547.f8. PMID: 31033711.
17: Verrotti A, Grasso EA, Cacciatore M, Matricardi S, Striano P. Potential role of brivaracetam in pediatric epilepsy. Acta Neurol Scand. 2021 Jan;143(1):19-26. doi: 10.1111/ane.13347. Epub 2020 Oct 13. PMID: 32966640.
18: Milovanović JR, Janković SM, Pejčić A, Milosavljević M, Opančina V, Radonjić V, Protrka Z, Kostić M. Evaluation of brivaracetam: a new drug to treat epilepsy. Expert Opin Pharmacother. 2017 Sep;18(13):1381-1389. doi: 10.1080/14656566.2017.1359260. Epub 2017 Jul 28. PMID: 28737479.
19: Stephen LJ, Brodie MJ. Brivaracetam: a novel antiepileptic drug for focal- onset seizures. Ther Adv Neurol Disord. 2017 Nov 23;11:1756285617742081. doi: 10.1177/1756285617742081. PMID: 29399049; PMCID: PMC5784556.
20: Papaliagkas V, Notas K, Chatzikyriakou E, Moschou M, Bostanjopoulou S, Hadjigeorgiou G, Kimiskidis VK. Brivaracetam for dyskinetic cerebral palsy. Epileptic Disord. 2022 Jun 1;24(3):614-616. English. doi: 10.1684/epd.2022.1431. PMID: 35653104.